31.12.2012 Views

Bulletin 2012/02 - European Patent Office

Bulletin 2012/02 - European Patent Office

Bulletin 2012/02 - European Patent Office

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

(C12N) I.1(1)<br />

• DIGUANYLATE CYCLASE, SON PROCÉDÉ<br />

DE PRODUCTION ET SON UTILISATION<br />

DANS LA FABRICATION DE DI-GMP<br />

CYCLIQUE ET DE SES ANALOGUES<br />

(71) Nanyang Technological University, 50<br />

Nanyang Avenue, Singapore 639 798, SG<br />

(72) LIANG, Zhao-Xun, Singapore 63998, SG<br />

RAO, Feng, Singapore 639 798, SG<br />

(74) KATZAROV S.A., <strong>European</strong> <strong>Patent</strong> Attorneys<br />

19, rue des Epinettes, 1227 Genève, CH<br />

C12N 9/<strong>02</strong> → (51) C12R 1/19<br />

C12N 9/04 → (51) C12N 1/21<br />

C12N 9/10 → (51) C12R 1/19<br />

C12N 9/16 → (51) C12R 1/19<br />

C12N 9/20 → (51) C12P 7/64<br />

(51) C12N 9/22 (11) 2 403 940 A2*<br />

C12N 15/66<br />

(25) En (26) En<br />

(21) 10707041.9 (22) 08.03.2010<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MK MT<br />

NL NO PL PT RO SE SI SK SM TR<br />

(86) EP 2010/052892 08.03.2010<br />

(87) WO 2010/10<strong>02</strong>78 2010/36 10.09.2010<br />

(88) <strong>02</strong>.12.2010<br />

(30) 06.03.2009 EP 09154567<br />

(54) • NUKLEINSÄUREN ZUR KLONIERUNG UND<br />

EXPRESSION VON MULTIPROTEINKOM-<br />

PLEXEN<br />

• NUCLEIC ACIDS FOR CLONING AND<br />

EXPRESSING MULTIPROTEIN COM-<br />

PLEXES<br />

• ACIDES NUCLÉIQUES POUR LE CLONAGE<br />

ET L'EXPRESSION DES COMPLEXES<br />

MULTIPROTÉIQUES<br />

(71) Europäisches Laboratorium für Molekularbiologie<br />

(EMBL), Meyerhofstrasse 1, 69117<br />

Heidelberg, DE<br />

(72) BERGER, Imre, F-38120 St. Egreve, FR<br />

(74) Habermann, Hruschka & Schnabel, Montgelasstrasse<br />

2, 81679 Munich, DE<br />

(51) C12N 9/22 (11) 2 403 941 A2*<br />

(25) En (26) En<br />

(21) 10749312.4 (22) 04.03.2010<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MK MT<br />

NL NO PL PT RO SE SI SK SM TR<br />

(86) US 2010/<strong>02</strong>6165 04.03.2010<br />

(87) WO 2010/1<strong>02</strong>085 2010/36 10.09.2010<br />

(88) 18.11.2010<br />

(30) 04.03.2009 US 157332 P<br />

(54) • STABILISIERTE REVERSE-TRANSKRIP-<br />

TASE-FUSIONSPROTEINE<br />

• STABILIZED REVERSE TRANSCRIPTASE<br />

FUSION PROTEINS<br />

• PROTÉINES DE FUSION DE TRANSCRIP-<br />

TASE INVERSE STABILISÉE<br />

(71) Board of Regents, The University of Texas<br />

System, 201 West Seventh Street, Austin, TX<br />

78701, US<br />

(72) LAMBOWITZ, Alan, M., Austin, TX 78746,<br />

US<br />

MOHR, Sabine, Austin, TX 78751, US<br />

MOHR, Georg, Austin, TX 78751, US<br />

GHANEM, Eman, Austin, TX 78759, US<br />

(74) Walton, Seán Malcolm, et al, Mewburn Ellis<br />

LLP 33 Gutter Lane, London EC2V 8AS, GB<br />

C12N 9/50 → (51) C07K 1/18<br />

C12N 9/88 → (51) C12R 1/19<br />

Europäisches <strong>Patent</strong>blatt<br />

<strong>European</strong> <strong>Patent</strong> <strong>Bulletin</strong><br />

<strong>Bulletin</strong> européen des brevets<br />

(51) C12N 15/00 (11) 2 403 942 A1*<br />

(25) En (26) En<br />

(21) 10749182.1 (22) <strong>02</strong>.03.2010<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MK MT<br />

NL NO PL PT RO SE SI SK SM TR<br />

(86) US 2010/<strong>02</strong>5872 <strong>02</strong>.03.2010<br />

(87) WO 2010/101884 2010/36 10.09.2010<br />

(30) 05.03.2009 US 157759 P<br />

(54) • STEUERUNG VON SCHLÜSSEL-ETHYLEN-<br />

HORMON-SIGNALISIERUNGSPFADPRO-<br />

TEINEN IN PFLANZEN<br />

• CONTROL OF KEY ETHYLENE HORMONE<br />

SIGNALING PATHWAY PROTEINS IN<br />

PLANTS<br />

• CONTRÔLE DES PROTÉINES CLÉS DES<br />

VOIES DE SIGNALEMENT DE L'HORMONE<br />

ÉTHYLÈNE CHEZ LES PLANTES<br />

(71) Rohm and Haas Company, 100 Independence<br />

Mall West, Philadelphia, PA 19106, US<br />

(72) ROSICHAN, Jeffrey, L., Ambler PA 190<strong>02</strong>,<br />

US<br />

(74) Buckley, Guy Julian, <strong>Patent</strong> Outsourcing<br />

Limited 1 King Street, Bakewell Derbyshire<br />

DE45 1DZ, GB<br />

(51) C12N 15/09 (11) 2 403 943 A1*<br />

A61K 39/00 A61K 48/00<br />

A61P 35/00 C07K 7/06<br />

C07K 14/705 C07K 16/30<br />

C12N 1/15 C12N 1/19<br />

C12N 1/21 C12N 5/07<br />

C12N 5/10<br />

(25) En (26) En<br />

(21) 10748479.2 (22) 01.03.2010<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MK MT<br />

NL NO PL PT RO SE SI SK SM TR<br />

(86) JP 2010/001366 01.03.2010<br />

(87) WO 2010/100878 2010/36 10.09.2010<br />

(30) 04.03.2009 US 209242 P<br />

(54) • VANGL1-PEPTIDE UND DIESE ENTHAL-<br />

TENDE IMPFSTOFFE<br />

• VANGL1 PEPTIDES AND VACCINES<br />

INCLUDING THE SAME<br />

• PEPTIDES VANGL1 ET VACCINS CONTE-<br />

NANT CES PEPTIDES<br />

(71) Oncotherapy Science, Inc., 2-1, Sakado 3chome<br />

Takatsu-ku, Kawasaki-shi Kanagawa<br />

213-0012, JP<br />

(72) TSUNODA, Takuya, Kawasaki-shi Kanagawa<br />

213-0012, JP<br />

OHSAWA, Ryuji, Kawasaki-shi Kanagawa<br />

213-0012, JP<br />

YOSHIMURA, Sachiko, Kawasaki-shi Kanagawa<br />

213-0012, JP<br />

WATANABE, Tomohisa, Kawasaki-shi Kanagawa<br />

213-0012, JP<br />

(74) Plougmann & Vingtoft A/S, Sundkrogsgade<br />

9 P.O. Box 831, 2100 Copenhagen Ø, DK<br />

(51) C12N 15/10 (11) 2 403 944 A2*<br />

(25) En (26) En<br />

(21) 10708854.4 (22) 05.03.2010<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MK MT<br />

NL NO PL PT RO SE SI SK SM TR<br />

(86) US 2010/<strong>02</strong>6434 05.03.2010<br />

(87) WO 2010/1<strong>02</strong>257 2010/36 10.09.2010<br />

(88) 20.01.2011<br />

(30) 06.03.2009 US 158320 P<br />

(54) • VERFAHREN ZUR KLONIERUNG UND<br />

MANIPULATION VON GENOMEN<br />

• METHODS FOR CLONING AND MANIPU-<br />

LATING GENOMES<br />

• PROCÉDÉS DE CLONAGE ET DE MANI-<br />

PULATION DE GÉNOMES<br />

(71) Synthetic Genomics, Inc., 11149 North<br />

Torrey Pines Road, La Jolla, CA 92037, US<br />

99<br />

Anmeldungen<br />

Applications<br />

Demandes (<strong>02</strong>/<strong>2012</strong>) 11.01.<strong>2012</strong><br />

(72) BENDERS, Gwynedd, A., Portland, OR<br />

97214-4240, US<br />

GLASS, John, I., Germantown, MD 20874,<br />

US<br />

HUTCHISON, Clyde, A., La Jolla, CA 92037,<br />

US<br />

LARTIGUE, Carole, 64100 Bayonne, FR<br />

VASHEE, Sanjay, Boyds, MD 20841, US<br />

ALGIRE, Mikkel, A., Jessup, MD 20794, US<br />

SMITH, Hamilton, O., San Diego, CA 92122,<br />

US<br />

MERRYMAN, Charles, E., Skyesville, MD<br />

21784, US<br />

NOSKOV, Vladimir, N., Montgomery Village,<br />

MD 20886, US<br />

CHUANG, Ray-Yuan, Rockville, MD 20850,<br />

US<br />

GIBSON, Daniel G., Crofton, MD 21114, US<br />

VENTER, J., Craig, La Jolla, CA 92037, US<br />

(74) Cornish, Kristina Victoria Joy, et al, Kilburn &<br />

Strode LLP 20 Red Lion Street, London<br />

WC1R 4PJ, GB<br />

(51) C12N 15/113 (11) 2 403 945 A2*<br />

A61K 31/713 A61P 35/00<br />

G06F 17/00<br />

(25) En (26) En<br />

(21) 10710091.9 (22) 01.03.2010<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MK MT<br />

NL NO PL PT RO SE SI SK SM TR<br />

(86) GB 2010/000360 01.03.2010<br />

(87) WO 2010/100404 2010/36 10.09.2010<br />

(88) 16.12.2010<br />

(30) <strong>02</strong>.03.2009 GB 0903562<br />

(54) • RNA-MOLEKÜLE UND THERAPEUTISCHE<br />

VERWENDUNGEN DAVON<br />

• RNA MOLECULES AND THERAPEUTIC<br />

USES THEREOF<br />

• MOLÉCULES D'ARN ET LEURS UTILISA-<br />

TIONS THÉRAPEUTIQUES<br />

(71) Mina Therapeutics Limited, 21 Wilson Street,<br />

London EC2M 2TD, GB<br />

(72) SÆTROM, Pàl, 7489 Trondheim, NO<br />

(74) Gardner, Rebecca Katherine, Dehns St<br />

Bride's House 10 Salisbury Square, London<br />

EC4Y 8JD, GB<br />

(51) C12N 15/113 (11) 2 403 946 A2*<br />

C12N 15/63 A61K 48/00<br />

(25) En (26) En<br />

(21) 10749298.5 (22) 03.03.2010<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MK MT<br />

NL NO PL PT RO SE SI SK SM TR<br />

(86) US 2010/<strong>02</strong>6119 03.03.2010<br />

(87) WO 2010/1<strong>02</strong>058 2010/36 10.09.2010<br />

(88) 31.03.2011<br />

(30) 04.03.2009 US 157255 P<br />

06.11.2009 US 259072 P<br />

<strong>02</strong>.12.2009 PCT/US2009/066445<br />

(54) • BEHANDLUNG VON SIRTUIN 1 (SIRT1)-<br />

BEDINGTEN ERKRANKUNGEN MITTELS<br />

HEMMUNG DES NATÜRLICHEN ANTI-<br />

SENSE-TRANSKRIPTS GEGEN SIRT 1<br />

• TREATMENT OF SIRTUIN 1 (SIRT1)<br />

RELATED DISEASES BY INHIBITION OF<br />

NATURAL ANTISENSE TRANSCRIPT TO<br />

SIRT 1<br />

• TRAITEMENT DE MALADIES LIÉES À<br />

SIRTUINE 1 (SIRT1) PAR INHIBITION<br />

D'UN PRODUIT DE TRANSCRIPTION<br />

ANTISENS NATUREL DE SIRT 1<br />

(71) Opko Curna, LLC, 4400 Biscayne Boulevard,<br />

Miami, FL 33137, US<br />

(72) COLLARD, Joseph, Delray Beach, FL 33483,<br />

US<br />

KHORKOVA SHERMAN, Olga, Tequesta, FL<br />

33469, US

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!